GNPXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Genprex, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$2.06−0.05 (-2.37%)
Close on Oct 19, 2026
- Market cap
- $974.71K
- P/E (TTM)
- –
- Dividend yield
- –
Fundamental chart
Pick a measure to chart its full history
–FY2025